Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 1 Published - 14:00 UTC    08:00 EST    30-July-2000      
Issue 108 Next Update - 14:00 UTC 08:00 EST    31-July-2000      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya



















Proceed To Article
Schizophrenia - A Complex Neurological Problem


Proceed To Article Unorthodox Schizophrenia Study To Be Expanded
A controversial experiment that targets adolescents believed to be at risk of developing schizophrenia is getting ready to expand. The study, the subject of a Wall Street Journal article on 26 July 2000, is expected to be funded primarily by the makers of schizophrenia drugs. More...

Proceed To Article Schizophrenia-Related Gene Site Reported
Researchers have discovered evidence for the existence of a gene on Chromosome 1 that appears to confer vulnerability to schizophrenia. Schizophrenia has long been known to involve a genetic component, but has so far eluded efforts to find susceptibility genes.More...

Proceed To Article for patientsWhen Someone Has Schizophrenia
Most people with schizophrenia suffer chronically or episodically throughout their lives, losing opportunities for careers and relationships. While newer treatments with fewer side effects have improved the lives of many people with schizophrenia, only one in five recovers. One in 10 commits suicide. More...

Proceed To Article Important Schizophrenia Drug Warning - Mellaril ® (Thioridazine HCl)
A boxed WARNING has been added to prominently advise clinicians that Mellaril (thioridazine HCl) has been shown to prolong the QTc interval in a dose related manner, and drugs with this potential, including Mellaril, have been associated with torsade de pointes-type arrhythmias and sudden death. More...

Proceed To Article

New Schizophrenia Therapies Show Promise, But Many Receive Inadequate Treatment
Recent advances in drugs and psychosocial therapies have made it possible, at least in theory, for people with schizophrenia to return to more normal lives. However, treatment of many patients with schizophrenia, particularly those cared for under the auspices of public programs like Medicaid and Medicare, remains inadequate. More...


Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.